Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 05 Jun 2026 for Xeris Biopharma Holdings, Inc..
Filing timeline
BuySaleBarbara-Jean Anne Bormann-Kennedy
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Barbara-Jean Anne Bormann-Kennedy: trading record in brief
Barbara-Jean Anne Bormann-Kennedy, listed as board member, appears in our data through filings on Xeris Biopharma Holdings, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 8 June 2022 to 4 June 2026, the count stands at 7 filings.
Sales make up the whole of the open-market record (2 sales, €175k). The rest of the record consists of 5 share grants. Since January 2026: no purchases and 1 sale on the market.
The newest entry dates from 5 June 2026: an open-market sale of €84k, in Xeris Biopharma Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Barbara-Jean Anne Bormann-Kennedy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
24,193 shares0Common StockSEC:0001635065-26-000002:1
16,000 shares@ US$6.09420.0042% mcap74.1% of flowCommon StockSEC:0001635065-26-000002:0
15,000 shares@ US$7.094344.4% of flowCommon StockSEC:0001635065-25-000004:0
50,000 shares0Common StockSEC:0001867096-25-000116:0
50,000 shares0Common StockSEC:0001867096-24-000107:0
42,500 shares0Common StockSEC:0001867096-23-000103:0
15,000 shares@ US$2.1014.4% of flowCommon StockSEC:0001867096-22-000094:0
7 of 7 declarations
